bioMerieux S.A. buy UBS Group AG
Start price
24.08.24
/
50%
€103.80
Target price
24.08.25
-
Performance (%)
22.64%
End price
25.08.25
€127.30
Summary
This prediction ended on 25.08.25 with a price of €127.30. The BUY prediction by UBS_Group_AG finished with a performance of 22.64%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| bioMerieux S.A. | 2.603% | 2.603% | -35.873% |
| iShares Core DAX® | 1,05 % | 4,90 % | 4,28 % |
| iShares Nasdaq 100 | 2,41 % | 11,65 % | 39,11 % |
| iShares Nikkei 225® | 4,16 % | 13,99 % | 52,53 % |
| iShares S&P 500 | 0,96 % | 6,36 % | 26,59 % |
Comments by UBS_Group_AG for this prediction
In the thread bioMerieux S.A. diskutieren
bioMérieux S.A. (OTCMKTS: BMXMF) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for BMXMF provided by MarketBeat
In the thread Trading bioMerieux S.A.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten